Insights into drug adverse reactions prediction through Mendelian randomization: a review

Zhuanqing Huang1, Hui Gong2, Xuemin Sun3

  • 1Department of Pharmacy, The No. 944 Hospital of Joint Logistic Support Force of PLA, 735099, Jiuquan, Gansu, China.

PubMed

Insights

Mendelian randomization (MR) analysis uses genetic data to predict adverse drug reactions before they happen, improving patient safety. This method reduces bias compared to traditional studies, advancing drug safety and personalized medicine.

Area of Science:

  • Pharmacovigilance
  • Genetic Epidemiology
  • Biostatistics

Background:

  • Adverse drug reactions (ADRs) are a major public health concern, often identified late.
  • Current observational studies for ADRs are susceptible to confounding factors.
  • Genetic variants offer potential for early ADR prediction.

Purpose of the Study:

  • To review the principles and applications of Mendelian randomization (MR) for predicting ADRs.
  • To discuss challenges and future directions in applying MR for drug safety.
  • To highlight MR's role in advancing personalized medicine and drug safety.

Main Methods:

  • Mendelian randomization (MR) analysis.
  • Utilizing genetic variants as instrumental variables.
  • Causal inference in epidemiological studies.

Main Results:

  • MR analysis can infer causality for ADRs using genetic predictors.
  • MR mitigates confounding bias inherent in traditional observational studies.
  • This approach enables prediction of ADRs prior to widespread clinical use.

Conclusions:

  • MR is a powerful tool for proactive adverse drug reaction prediction.
  • Harnessing MR can enhance drug safety assessments and personalized medicine.
  • Further research and application of MR are crucial for public health.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
219
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.7K